FDA inspection
Johns Hopkins Medicine Institutional Review Boards: FDA inspection ending Oct 30, 2020
FDA inspection 1133675 · No Action Indicated (NAI) · Baltimore, MD
Key facts
| Inspection ID | 1133675 |
|---|---|
| Firm | Johns Hopkins Medicine Institutional Review Boards |
| FEI number | 1120913 |
| Address | 1620 McElderry St |
| City | Baltimore |
| State | MD |
| ZIP | 21205 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Oct 30, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data